Lupin and SteinCares enter into License and Supply Agreement for Ranibizumab in Latin America
SteinCares will handle all regulatory filings, registrations and commercialisation of Ranibizumab in LATAM, while Lupin will be…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
Biocon Biologics gains contract extension for Insulins supply by Malaysian MoH
The amendment to the contract will be formalised through the execution of a formal supplementary agreement between the MoH, DMktg…
Senores Pharmaceuticals gains ANDA for Enalapril Maleate Tablets 2.5mg, 5mg, 10mg and 20mg from…
Enalapril is indicated as a treatment of hypertension, heart failure, and asymptomatic left ventricular dysfunction
Barentz acquires Fengli, China, aims to strengthen market presence
The partnership would further enhance the service and commercial capabilities of Barentz in China while enabling Fengli Group to…
Pfizer enters into an exclusive licensing agreement with 3SBio
Under the terms of the agreement, 3SBio will grant Pfizer an exclusive global license to develop, manufacture and commercialise…
Novopor acquires US-based Pressure Chemical Company
Acquisition aims to expand capabilities in high-pressure chemistry and complex specialty manufacturing, advancing…
Deal value drops by 34.2 per cent in April 2025, compared to April 2024
GlobalData reveals the pharma and healthcare industry reported 81 deals worth $9.6 billion and 85 venture capital deals worth $2…
TPG acquires 35% stake in SCHOTT Poonawalla JV
Serum Institute of India will retain a minority stake in the company, with SCHOTT Pharma maintaining 50 per cent ownership
Bio-Thera, Dr. Reddy’s partner to commercialise BAT2206, a proposed Stelara Biosimilar, and BAT2506,…
Under the agreement, Bio-Thera will develop, manufacture, and supply BAT2206 and BAT2506. Dr. Reddy’s will seek regulatory…
Cohance Lifesciences, Suven Pharmaceuticals merger sanctioned by the NCLT
The Company expects to complete the amalgamation process by Q1FY26
DKSH Technology Acquires Taqkey Science and Quantum Biotech, two technology distribution companies…
DKSH has signed an agreement to acquire Taqkey Science and Quantum Biotech in Taiwan. With these transactions, DKSH Technology…
AstraZeneca to invest $2.5 bn in new R&D centre, biotech agreements and manufacturing in…
In addition, AstraZeneca is launching a new joint venture with BioKangtai, to develop, manufacture, and commercialise innovative…
Syngene concludes acquisition of Emergent BioSolutions’ biologics manufacturing facility
The new site will increase Syngene’s total single-use bioreactor capacity to 50,000L for large molecule discovery, development,…
Cipla, Formosa sign multi-regional licensing deal for Clobetasol Suspension
This partnership aims to enhance ophthalmic care by providing treatment for post- operative inflammation and pain in patients…
Shilpa Biologicals partners with mAbTree Biologics for novel immuno-oncology asset
Shilpa to undertake both development and commercial supply for mAbTree’s novel checkpoint inhibitor
Peptris Technologies out-licenses AI-discovered drug candidate to Revio Therapeutics
Under the agreement, Revio Therapeutics will hold commercialisation rights to PEPR124 (RT001) in all markets except in BRICS…
AstraZeneca to acquire EsoBiotec to advance cell therapy ambition
EsoBiotec will become a wholly owned subsidiary of AstraZeneca, with operations in Belgium
India and Belgium unite to advance RNA-based vaccines
As part of this collaboration, TechInvention is introducing Quantoom’s RNA manufacturing solutions—to India with a focus on…
Senores Pharma acquires 14 ANDAs from Dr. Reddy’s
The basket acquired comprises 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA
Sun Pharma subsidiary Taro acquires Antibe Therapeutics
Antibe Therapeutics is a clinical-stage biotechnological company based in Ontario, Canada